New hope for rare epilepsy: experimental drug aims to cut seizures in half
NCT ID NCT07010471
First seen Nov 01, 2025 · Last updated May 19, 2026 · Updated 26 times
Summary
This study tests an experimental drug called relutrigine in 160 people with a severe, early-onset epilepsy called developmental and epileptic encephalopathy (DEE). The goal is to see if the drug can safely reduce monthly seizures compared to a placebo. After the main study, all participants can receive the drug in an open-label extension.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 1 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Praxis Research Site
RECRUITINGLa Jolla, California, 92037, United States
-
Praxis Research Site
RECRUITINGGulf Breeze, Florida, 32561, United States
-
Praxis Research Site
RECRUITINGChevy Chase, Maryland, 20815, United States
-
Praxis Research Site
RECRUITINGRoseville, Minnesota, 55113, United States
-
Praxis Research Site
RECRUITINGHackensack, New Jersey, 07601, United States
-
Praxis Research Site
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
Praxis Research Site
RECRUITINGHeidelberg, Victoria, 3084, Australia
-
Praxis Research Site
RECRUITINGRio Grande, Do Sul, 90610, Brazil
-
Praxis Research Site
RECRUITINGParaná, 80250, Brazil
-
Praxis Research Site
RECRUITINGRio de Janeiro, 20231, Brazil
-
Praxis Research Site
RECRUITINGSão Paulo, 15090, Brazil
Conditions
Explore the condition pages connected to this study.